- About EAS
Dr. Michal Vrablik's main interests include preventive cardiology, clinical lipidology and genetics of lipoprotein metabolism disorders. He is the chairman of the Czech Atherosclerosis Society, member of the EAS Executive Committee and, also, member of board of several national expert societies.
He is a co-organizer of annual International Atherosclerosis Research School for young MD and PhD students interested in the field of atherosclerosis. He was actively involved in the organization of the 75th EAS congress in Prague as well as the EAS Advanced course in clinical lipidology and CVD prevention.
He has served as a principal investigator and investigator in more than thirty research projects on familial dyslipidemias and cardiovascular disease risk and has participated in a number of international clinical trials. He regularly presents at national as well as international scientific meetings. Dr. Vrablik has authored and co-authored more than 100 papers in peer-reviewed scientific journals. He is an author of ten chapters in monographs. He is also a reviewer for several national and international journals.